Integer Holdings Valuation Multiples

Integer Holdings Overview

About Integer Holdings

Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns maximum of its revenue in the United States, and also has its presence in Ireland, Puerto Rico, Costa Rica, and Rest of the World.

Founded

1997

HQ

Employees

11.4K

Website

integer.net

Sectors

Medical DevicesDeepTechHealthTech

Financials (LTM)

Revenue: $2B

EBITDA: $402M

EV

$4B

Valuation Multiples

Multiples.vc

Start free trial

Integer Holdings Financials

Integer Holdings reported last 12-month revenue of $2B and EBITDA of $402M.

In the same LTM period, Integer Holdings generated $510M in gross profit, $402M in EBITDA, and $111M in net income.

Integer Holdings P&L

In the most recent fiscal year, Integer Holdings reported revenue of $2B and EBITDA of $402M.

Integer Holdings expects next 12-month revenue of XXX and NTM EBITDA of XXX

Integer Holdings Stock Performance

Integer Holdings has current market cap of $3B, and enterprise value of $4B.

Integer Holdings' stock price is $86.34.

Integer Holdings Valuation Multiples

Integer Holdings trades at 2.3x EV/Revenue multiple, and 10.6x EV/EBITDA.

Integer Holdings Financial Valuation Multiples

As of March 31, 2026, Integer Holdings has market cap of $3B and EV of $4B.

Equity research analysts estimate Integer Holdings' 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Integer Holdings has a P/E ratio of 26.6x.

Integer Holdings Margins & Growth Rates

Integer Holdings' revenue in the last 12 month grew by 1%.

Integer Holdings' revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.0M for the same period.

Integer Holdings' rule of 40 is 21% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Integer Holdings' rule of X is 21% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Integer Holdings Public Comps

See public comps and valuation multiples for other Medical Devices comps.

Integer Holdings M&A Activity

Integer Holdings acquired XXX companies to date.

Last acquisition by Integer Holdings was on XXXXXXXX, XXXXX. Integer Holdings acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

Integer Holdings Investment Activity

Integer Holdings invested in XXX companies to date.

Integer Holdings made its latest investment on XXXXXXXX, XXXXX. Integer Holdings invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).